Carlos Zgheib

Carlos Zgheib, PhD, MS, currently serves as the Chief Scientific Officer at Ceria Therapeutics, leading the development of innovative drug therapies for critical conditions such as ALI/ARDS, DFU, PU, and IBD. In addition, Carlos holds multiple positions as an Associate Professor at the University of Arizona in Biomedical Engineering, Pharmacology, and Surgery, while co-leading the NIH-funded Laboratory for Fetal and Regenerative Biology. Carlos's extensive experience includes previous roles at the University of Colorado Anschutz Medical Campus, Children's Hospital Colorado, and several leading research institutes where responsibilities encompassed R&D management, strategic partnerships, and public speaking engagements at major conferences. Carlos's educational background includes a PhD in Medical Pharmacology and Toxicology, multiple master's degrees, and a foundation in Biochemistry from Holy Spirit University of Kaslik.